Balance Therapeutics Overview
- Year Founded
-
2009
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
Balance Therapeutics General Information
Description
Developer of pharmaceutical therapies designed to address neurological disabilities resulting from excess inhibition of the brain. The company's therapies offer a pharmacological approach to address cognitive deficits related to Down syndrome and Alzheimer's disease, enabling patients to get advanced therapy for their diseases and recover at a faster rate.
Contact Information
Website
www.balance-therapeutics.comCorporate Office
- 533 Airport Boulevard
- Suite 400
- Burlingame, CA 94010
- United States
Corporate Office
- 533 Airport Boulevard
- Suite 400
- Burlingame, CA 94010
- United States
Balance Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 28-Oct-2020 | Completed | Out of Business | |||
| 7. Later Stage VC | 19-Mar-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 17-Feb-2016 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 19-May-2015 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 18-Mar-2015 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2012 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Feb-2011 | $11M | $11M | Completed | Generating Revenue | |
| 1. Grant | 01-Jan-2011 | $363K | Completed | Generating Revenue |
Balance Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 13,469,555 | $0.001000 | $0.06 | $1 | $1 | 1x | $1 | 25.11% |
Balance Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Balance Therapeutics Patents
Balance Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2017511386-A | Methods for treating hypersomnia | Active | 15-Apr-2014 | ||
| JP-2020105200-A | Methods for treating hypersomnia | Pending | 15-Apr-2014 | ||
| CA-2945705-A1 | Methods for treating hypersomnia | Inactive | 15-Apr-2014 | ||
| EP-3131904-A4 | Methods for treating hypersomnia | Inactive | 15-Apr-2014 | ||
| EP-3131904-A1 | Methods for treating hypersomnia | Inactive | 15-Apr-2014 | A61K31/55 |
Balance Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Balance Therapeutics FAQs
-
When was Balance Therapeutics founded?
Balance Therapeutics was founded in 2009.
-
Where is Balance Therapeutics headquartered?
Balance Therapeutics is headquartered in Burlingame, CA.
-
What is the size of Balance Therapeutics?
Balance Therapeutics has 3 total employees.
-
What industry is Balance Therapeutics in?
Balance Therapeutics’s primary industry is Pharmaceuticals.
-
Is Balance Therapeutics a private or public company?
Balance Therapeutics is a Private company.
-
What is Balance Therapeutics’s current revenue?
The current revenue for Balance Therapeutics is .
-
How much funding has Balance Therapeutics raised over time?
Balance Therapeutics has raised $75.2M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
